Table 3 Medication variables description along study visits (n = 162), Goiânia—GO
Visit 1 | Visit 2 | Visit 3 | p valuea | |
|---|---|---|---|---|
Number of anti-HTN | 1.6 (± 0.9) | 2.1 (± 0.9) | 2.8 (± 0.8) | < 0.001 |
ACE inhibitors/ARBs | 102 (63.0%) | 134 (82.7%) | 150 (92.6%) | < 0.001 |
Aspirin | 27 (16.7%) | 47 (29.0%) | 52 (32.1%) | 0.045 |
Statins | 46 (28.4%) | 66 (40.7%) | 98 (60.5%) | < 0.001 |
Oral hypoglycemic agents | 84 (51.9%) | 146 (90.1%) | 150 (92.6%) | < 0.001 |
Insulin | 12 (7.4%) | 19 (11.7%) | 33 (20.4%) | 0.001 |
Treatment compliance | 55 (34.0%) | 84 (51.9%) | 111 (68.9%) | < 0.001 |